Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Invitae nets $291.2mm via private notes offering

Executive Summary

Genetic testing firm Invitae Corp. netted $291.2mm through an upsized private offering of $300mm aggregate principle amount of 2% senior notes due 2024. The notes convert to common at a rate of 33.6293 shares per $1k principal amount, or $29.74 per share. (Invitae's stock averaged $24.46 at the time of the transaction.) Invitae originally planned to issue $200mm of the notes.
Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies